-23.7%
NVO vs PSA
+22.6%
-46.3%
-74.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | PSA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -0.4% | -2.3% | -2.6% |
| 7D | -9.2% | -2.2% | -7.0% | -8.7% |
| 30D | -3.2% | +9.1% | -12.3% | -4.9% |
| 3M | -18.0% | +1.9% | -19.9% | -18.4% |
| 6M | -15.0% | +9.6% | -24.6% | -16.7% |
| YTD | -22.0% | +29.2% | -51.1% | -26.1% |
| 1Y | -16.6% | +27.7% | -44.2% | -20.8% |
| 3Y | -60.2% | +42.3% | -102.5% | -62.9% |
| All | -23.7% | +22.6% | -46.3% | -30.2% |
Cumulative growth
Daily Returns
Daily percentage return beside PSA.
Daily Out/Under-Performance
Portfolio return minus PSA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded PSA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling